Survival analyses have demonstrated that higher PON2 levels are linked to significantly reduced patient survival, while silencing PON2 inhibits cancer cell migration, proliferation, and metastatic potential (Bacchetti et al. 2017). The gene discussed is PON2; the disease is cancer.